Gut bacteria study after fecal transplant for C. diff
Part of Digestive system, Infections clinical trials.
This study looks at how gut bacteria change after a fecal transplant for recurrent C. diff infection. It helps researchers understand which bacteria help fight the infection and which might resist treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have recurrent C. diff infection and are over 18 years old.
- You have not taken antibiotics in the last 30 days.
- You have not taken probiotics, prebiotics, or postbiotics in the last 60 days.
- You do not have multidrug-resistant bacteria in your gut.
- You do not have other serious bowel diseases like Crohn's, colitis, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fecal microbiota transplantation (FMT) affects the gut microbiome in people with ulcerative colitis, metabolic syndrome, or recurrent C. diff infection. It aims to understand how the donor bacteria settle in the gut.
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
This Phase 1 study tests defined fecal microbiota (healthy gut bacteria) given to people with C. difficile diarrhea that didn’t go away or came back soon after antibiotics. It may help by restoring a healthier balance of gut bacteria so the infection can stop recurring.
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
This study looks at how fecal microbiota transplantation (a transplant of healthy gut bacteria) works for people who get C. difficile infection repeatedly. It also focuses on collecting follow-up information to better understand which patients benefit and how.
This Phase 2 study tests whether placing stool from a healthy donor into your gut can treat repeated, hard-to-control C. difficile colitis. It may help restore healthy gut bacteria and reduce future flare-ups.
Hear when a new CDI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.